BFC Planning’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
BFC Planning's CODX Position: Q3 2026 in Review
BFC Planning held its Co-Diagnostics (CODX) position steady in Q3 2026 at 8 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #3449.
BFC Planning first reported a position in CODX in Q2 2026 and has held it in 2 quarters since. The position peaked at $25 in Q2 2026. 20 funds tracked by Wall St. Rank hold CODX as of Q3 2026.
- BFC Planning held 8 shares of Co-Diagnostics worth $9 as of Q3 2026.
- BFC Planning left its Co-Diagnostics share count unchanged in Q3 2026.
- Co-Diagnostics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3449 holding.
- BFC Planning first reported a position in Co-Diagnostics in Q2 2026 and has held it in 2 quarters since.
- BFC Planning's Co-Diagnostics position peaked at $25 in Q2 2026.
- 20 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.